A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
Public ClinicalTrials.gov record NCT05491447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Clinical Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 Ointment in Adult Subjects With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2 clinical trial conducted in 2 parts: Part 1 - Pharmacokinetics and Part 2 - Randomized and Placebo Controlled (subject and clinical assessors will be blinded). Study Product will be applied to AD BID days 1-28. There will be weekly visits from Baseline (day 1) through Day 29. There is a final follow up visit 2 weeks after.
Study identification
- NCT ID
- NCT05491447
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 103 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 8, 2023 (Actual)
- Primary completion
- Dec 30, 2023 (Actual)
- Completion
- Apr 15, 2024 (Actual)
- Last update posted
- Apr 18, 2024
2023 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology & Skin Health Center | Birmingham | Alabama | 35244 | — |
| Dermatology Trial Associates | Bryant | Arkansas | 72022 | — |
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Axon Clinical Research | Inglewood | California | 90301 | — |
| Colorado Skin Care | Englewood | Colorado | 80113 | — |
| Skin Care Research | Boca Raton | Florida | 33486 | — |
| Driven Research LLC | Coral Gables | Florida | 33134 | — |
| RM Medical Research | Miami Lakes | Florida | 33014 | — |
| Lenus Research | Sweetwater | Florida | 33172 | — |
| Physicians Research Group | West Lafayette | Indiana | 47906 | — |
| Skin Sciences, Pllc | Louisville | Kentucky | 40241 | — |
| Clinical Trials Management, LLC | Mandeville | Louisiana | 70448 | — |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | — |
| National Allergy and Asthma Research, LLC. | North Charleston | South Carolina | 29420 | — |
| J&S Studies, Inc. | College Station | Texas | 77845 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Jordan Valley Dermatology Center | South Jordan | Utah | 84095 | — |
| Dermatology Specialists of Spokane (Dermatology Specialists of Spokane, PLLC) | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05491447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05491447 live on ClinicalTrials.gov.